Immuron IMRN
NASDAQ IMRN
$0.97 -0.05 (-4.90%)
At close: Oct 21, 2026 · 4:00 PM EDT

Immuron (IMRN) Change in Receivables (2018 - 2021)

Updated

Immuron (IMRN) reported Change in Receivables of $350,640 for FY2026 (year ended Jun 30, 2026), compared with -$361,172 in FY2025.

Analysis

Immuron (IMRN) Change in Receivables (2018 - 2021) Analysis & Trends

Dating back to FY2018, Immuron's Change in Receivables record includes 9 fiscal years.

  • Change in Receivables has a five-year compound annual growth rate of 82.7% (FY2021 to FY2026).
  • The FY2026 figure ranks as the highest annual Change in Receivables since FY2020.
  • According to Business Quant data, Change in Receivables came in at -$361,172 in FY2025, -$628,608 in FY2024, $152,438 in FY2023 and -$244,649 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.35 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 1.37 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 333.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Immuron 7.32 Mn -9.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 17,739.76
Sep 1, 2020 641,236.00
Jun 30, 2020 420,279.30
Dec 31, 2019 680,337.00
Aug 30, 2019 680,337.00
Dec 31, 2018 438,001.00
API Access

Immuron Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=IMRN&period=max&api_key=YOUR_API_KEY